D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 112 Citations 45,555 911 World Ranking 2238 National Ranking 91

Overview

What is he best known for?

The fields of study he is best known for:

  • Law
  • Acquired immunodeficiency syndrome
  • Internal medicine

His main research concerns Public health, Substance abuse, Acquired immunodeficiency syndrome, Psychiatry and Cohort. The various areas that Thomas Kerr examines in his Public health study include Family medicine, SAFER, Drug and Environmental health. His biological study spans a wide range of topics, including Internal medicine, Pharmacotherapy, Suicide prevention and Immunology.

His work in Psychiatry addresses issues such as Epidemiology, which are connected to fields such as Injection drug use. His Cohort research incorporates elements of Odds ratio, Cohort study, Heroin, Demography and Emergency medicine. His Cohort study research is multidisciplinary, relying on both Methadone, Prospective cohort study and Gee.

His most cited work include:

  • Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study (651 citations)
  • Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study (651 citations)
  • The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic (455 citations)

What are the main themes of his work throughout his whole career to date?

Psychiatry, Prospective cohort study, Odds ratio, Cohort and Public health are his primary areas of study. As a part of the same scientific study, Thomas Kerr usually deals with the Psychiatry, concentrating on Acquired immunodeficiency syndrome and frequently concerns with Immunology. His work deals with themes such as Demography, Proportional hazards model, Cohort study and Hazard ratio, which intersect with Prospective cohort study.

Syringe is closely connected to Harm reduction in his research, which is encompassed under the umbrella topic of Odds ratio. The Cohort study combines topics in areas such as Gee, Incidence, Viral load, Emergency medicine and Risk factor. Thomas Kerr has researched Public health in several fields, including Law enforcement, SAFER, Family medicine and Environmental health.

He most often published in these fields:

  • Psychiatry (50.15%)
  • Prospective cohort study (39.61%)
  • Odds ratio (38.82%)

What were the highlights of his more recent work (between 2017-2021)?

  • Odds ratio (38.82%)
  • Prospective cohort study (39.61%)
  • Demography (29.26%)

In recent papers he was focusing on the following fields of study:

Thomas Kerr spends much of his time researching Odds ratio, Prospective cohort study, Demography, Confidence interval and Harm reduction. His Odds ratio research focuses on subjects like Cohort, which are linked to Sexual violence. His Prospective cohort study research integrates issues from Cohort study, Heroin, Family medicine, Proportional hazards model and Hazard ratio.

His research in Family medicine intersects with topics in Health care, Substance abuse and Acquired immunodeficiency syndrome. His Harm reduction study combines topics in areas such as Psychological intervention, Syringe, Environmental health, Criminology and Drug. His study focuses on the intersection of Drug and fields such as Opioid overdose with connections in the field of Psychiatry.

Between 2017 and 2021, his most popular works were:

  • Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada (63 citations)
  • Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada (63 citations)
  • Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada (48 citations)

In his most recent research, the most cited papers focused on:

  • Law
  • Acquired immunodeficiency syndrome
  • Internal medicine

Thomas Kerr mainly investigates Harm reduction, Confidence interval, Odds ratio, Demography and Prospective cohort study. His Harm reduction study integrates concerns from other disciplines, such as Criminology, Criminalization, Drug and Environmental health. He has included themes like Gee, Methadone, Opioid use disorder, Odds and Emergency medicine in his Odds ratio study.

He combines subjects such as Cannabis, Naloxone and Cohort with his study of Demography. His Prospective cohort study research is multidisciplinary, incorporating perspectives in Proportional hazards model and Hazard ratio. His Social policy research is multidisciplinary, incorporating elements of Psychological intervention and Public health.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

Julio S.G. Montaner;Julio S.G. Montaner;Julio S.G. Montaner;Viviane D. Lima;Viviane D. Lima;Rolando Barrios;Benita Yip.
The Lancet (2010)

897 Citations

The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic

Julio S. G. Montaner;Robert Hogg;Evan Wood;Thomas Kerr.
The Lancet (2006)

652 Citations

Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work

Kate Shannon;Thomas Kerr;Shari Allinott;Jill Chettiar.
Social Science & Medicine (2008)

536 Citations

Public health and international drug policy

Joanne Csete;Adeeba Kamarulzaman;Michel Kazatchkine;Frederick Altice.
The Lancet (2016)

396 Citations

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study

Evan Wood;Thomas Kerr;Brandon D L Marshall;Kathy Li.
BMJ (2009)

392 Citations

Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

Brandon D. L. Marshall;M.-J. Milloy;Evan Wood;Julio S. G. Montaner.
The Lancet (2011)

380 Citations

Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers.

Kate Shannon;Thomas Kerr;Steffanie A. Strathdee;Jean Shoveller.
BMJ (2009)

351 Citations

The public health and social impacts of drug market enforcement: A review of the evidence

Thomas Kerr;Thomas Kerr;Will Small;Evan Wood;Evan Wood.
International Journal of Drug Policy (2005)

347 Citations

Structural and Environmental Barriers to Condom Use Negotiation With Clients Among Female Sex Workers: Implications for HIV-Prevention Strategies and Policy

Kate Shannon;Steffanie A. Strathdee;Jean Shoveller;Melanie Rusch.
American Journal of Public Health (2009)

342 Citations

Safer injection facility use and syringe sharing in injection drug users

Thomas Kerr;Thomas Kerr;Mark Tyndall;Mark Tyndall;Kathy Li;Kathy Li;Julio Montaner;Julio Montaner.
The Lancet (2005)

327 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas Kerr

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 255

Steffanie A. Strathdee

Steffanie A. Strathdee

University of California, San Diego

Publications: 218

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 212

Kate Shannon

Kate Shannon

University of British Columbia

Publications: 129

Frederick L. Altice

Frederick L. Altice

Yale University

Publications: 123

Louisa Degenhardt

Louisa Degenhardt

University of New South Wales

Publications: 118

Evan Wood

Evan Wood

University of British Columbia

Publications: 112

Benedikt Fischer

Benedikt Fischer

Federal University of Sao Paulo

Publications: 100

Susan G. Sherman

Susan G. Sherman

Johns Hopkins University

Publications: 98

Lisa Maher

Lisa Maher

University of New South Wales

Publications: 94

Margaret Hellard

Margaret Hellard

Burnet Institute

Publications: 90

Leo Beletsky

Leo Beletsky

Northeastern University

Publications: 90

Jason Grebely

Jason Grebely

University of New South Wales

Publications: 87

Don C. Des Jarlais

Don C. Des Jarlais

New York University

Publications: 86

Brandon D. L. Marshall

Brandon D. L. Marshall

Brown University

Publications: 80

Matthew Hickman

Matthew Hickman

University of Bristol

Publications: 79

Trending Scientists

Franz Baader

Franz Baader

TU Dresden

Song Han

Song Han

MIT

Alexander M. Haimovich

Alexander M. Haimovich

New Jersey Institute of Technology

Raed A. Abd-Alhameed

Raed A. Abd-Alhameed

University of Bradford

Thomas Hellweg

Thomas Hellweg

Bielefeld University

Gary K. Ackers

Gary K. Ackers

Washington University in St. Louis

Mingshu Yang

Mingshu Yang

Chinese Academy of Sciences

Chunxia Li

Chunxia Li

Chinese Academy of Sciences

Tetsuya Yanagida

Tetsuya Yanagida

Yamaguchi University

Alessandra Zambonelli

Alessandra Zambonelli

University of Bologna

Hermann M. Niemeyer

Hermann M. Niemeyer

University of Chile

Gregory T. Spear

Gregory T. Spear

Rush University Medical Center

Daniel F. Belknap

Daniel F. Belknap

University of Maine

John M. Pearce

John M. Pearce

Cardiff University

Peter L. Lakatos

Peter L. Lakatos

McGill University

William P. Dunlap

William P. Dunlap

Tulane University

Something went wrong. Please try again later.